Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

China Immunotech (beijing) Biotechnology Co., Ltd.

Clinical trials sponsored by China Immunotech (beijing) Biotechnology Co., Ltd., explained in plain language.

Trials to join now! 4 Not yet recruiting 1 Completed 1

Experimental cell therapy tested for Tough-to-Treat blood disorder

Disease control Completed

This early-stage study tested the safety and initial effectiveness of a new cell therapy called YTS109 for people with severe autoimmune hemolytic anemia (AIHA) who haven't responded to at least three previous treatments. The trial involved just 7 participants and focused on find…

Phase: PHASE1 • Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd. • Aim: Disease control

Last updated Mar 30, 2026 14:31 UTC